Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
Mori Arkin

CTech 24/7

Mori Arkin

5 stories about Mori Arkin

Exalenz Bioscience Acquired for $49M
19.02.20|Golan HazaniIsraeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
19.02.20|Golan HazaniTel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source
Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel
20.02.18|Meir OrbachThe incubator program has a five year budget of 20 million euros
Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO
31.08.17|Dror ReichThe clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
Anti-Acne Drug Developer Plans Nasdaq IPO
15.08.17|Golan HazaniSol-Gel approached potential underwriters. It aims to go public before the end of the year

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Mori Arkin

Exalenz Bioscience Acquired for $49M

Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company

Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

Anti-Acne Drug Developer Plans Nasdaq IPO